Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapy

Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapy

US Patent 11992537 · Granted May 28, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Radiolabelled compounds for diagnosis or treatment of prostate-specific membrane2025
Dual mode 18F-labelled theranostic compounds and uses thereof2025
Dual mode 18F-labelled theranostic compounds and uses thereof2025
Dual mode 18F-labelled theranostic compounds and uses thereof2025
Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor2025
Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor2025
Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor2025
Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor2025
LILRB4 antibodies and uses thereof2025
Control method and system for hybrid power system2024
Hybrid power system2024
Methods for identifying LILRB-blocking antibodies2024